Unilife UNS (UNIS in the US) is another that trades as a CDI.
A company that is in a similar position as AJX (maybe a little bit more advanced) in that its begun the process of commercializing its research in retractable syringes and wearable injectors and signing contracts.Wearable injectors also a potential billion dollar market.
Also a stock that shows that listing in the US doesn't necessarily guarantee anything. CEO has promised a lot over the years in terms of multiple contracts "about" to be signed and while there has been a flow of contract signings, the company is still yet to turn a profit. Its share price yet to recover to its highs.
Not saying that Nick at AJX has under delivered on anything, been happy with his performance and news flow. But just saying do not pin hopes on a rise in share price just due to a US listing, AJX will need to still need to put the runs on the board contracts wise.
AJX Price at posting:
58.0¢ Sentiment: Buy Disclosure: Held
